LK
Laurie B. Keating
SVP and General Counsel

Laurie B. Keating insider trades: Millennium Pharmaceuticals (MLNM) stock sales

SVP and General Counsel, Millennium Pharmaceuticals Last trade Mar 11, 2008 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2007
1
Company
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Laurie reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 11, 2008MLNM↓ Sell$130K
Mar 3, 2008MLNM↓ Sell$143K
Jan 4, 2008MLNM↓ Sell$156K
Dec 6, 2007MLNM↓ Sell$26K
Nov 5, 2007MLNM↓ Sell$317K
Mar 20, 2007MLNM↓ Sell$136K
Mar 13, 2007MLNM↓ Sell$280K
Feb 12, 2007MLNM↓ Sell$333K
Jan 4, 2007MLNM↓ Sell$59K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Laurie B. Keating's insider trades

Laurie B. Keating is SVP and General Counsel at Millennium Pharmaceuticals (MLNM). Since Jan 4, 2007, Laurie has reported no open-market purchases and 9 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), option exercises (4 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLNM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.